April 29, 2021
By Jill K. MacAlpine, Ph.D.; Alissa K. Lipton; Sara A. Leiman, Ph.D.; Oulu (Lulu) Wang, Ph.D.
The Life Sciences industry can be particularly challenging for companies to navigate, often requiring careful navigation through rigorous testing and regulatory compliance. The Life Sciences Podcasts Series looks at some of the hottest topics in the Life Sciences industry. In this podcast, Finnegan attorneys Jill MacAlpine, Alissa Lipton, Lulu Wang, and Sara Leiman discuss the doctrine of inherency and obviousness and identify notable, recent decisions in the life sciences industry.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Federal Circuit IP Blog
March 21, 2024
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
Ad Law Buzz Blog
“Banning” a Banned Ingredients Claim: NAD’s Application (and Expansion) of the FTC’s Green Guides
March 18, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.